Abstract
purpose. To examine baseline measurements of accommodative lag, phoria, reading distance, amount of near work, and level of myopia as risk factors for progression of myopia and their interaction with treatment over 3 years, in children enrolled in the Correction of Myopia Evaluation Trial (COMET).
methods. COMET enrolled 469 ethnically diverse children (ages, 6–11 years) with myopia between −1.25 and −4.50 D. They were randomly assigned to either progressive addition lenses (PALs) with a +2.00 addition (n = 235) or single vision lenses (SVLs; n = 234), the conventional spectacle treatment, and were observed for 3 years. The primary outcome measure was progression of myopia by autorefraction after cycloplegia with 2 drops of 1% tropicamide. Other measurements included accommodative response (by an open field of view autorefractor), phoria (by cover test), reading distance, and hours of near work. Independent and interaction analyses were based on the mean of the two eyes. Results were adjusted for important covariates with multiple linear regression.
results. Children with larger accommodative lags (>0.43 D for a 33 cm target) wearing SVLs had the most progression at 3 years. PALs were effective in slowing progression in these children, with statistically significant 3-year treatment effects (mean ± SE) for those with larger lags in combination with near esophoria (PAL − SVL progression = −1.08 D − [−1.72 D] = 0.64 ± 0.21 D), shorter reading distances (0.44 ± 0.20 D), or lower baseline myopia (0.48 ± 0.15 D). The 3-year treatment effect for larger lags in combination with more hours of near work was 0.42 ± 0.26 D, which did not reach statistical significance. Statistically significant treatment effects were observed in these four groups at 1 year and became larger from 1 to 3 years.
conclusions. The results support the COMET rationale (i.e., a role for retinal defocus in myopia progression). In clinical practice in the United States children with large lags of accommodation and near esophoria often are prescribed PALs or bifocals to improve visual performance. Results of this study suggest that such children, if myopic, may have an additional benefit of slowed progression of myopia.
The Correction of Myopia Evaluation Trial (COMET) was a prospective, randomized clinical trial that evaluated the effect of progressive addition lenses (PALs) compared with single vision lenses (SVLs) on the progression of juvenile-onset myopia.
1 2 3 Four hundred sixty-nine ethnically diverse 6- to 11-year-old children with baseline spherical equivalent myopia between −1.25 and −4.50 D were randomized to either SVLs, the conventional correction for myopia, or PALs with a +2.0 addition. The rationale for the trial was that PALs might slow myopia progression by reducing the amount of retinal defocus experienced by the children. Additional support for the trial was provided by a report that PALs significantly slowed the progression of myopia by approximately 0.50 D after 2 years in 80 Chinese children.
4 More recently, smaller treatment effects have been reported in two other studies of PALs and SVLs in Chinese children.
5 6
The primary outcome of COMET was a statistically significant (P = 0.004) but clinically inconsequential adjusted difference in 3-year myopia progression of 0.20 ± 0.08 D. Myopia in PAL wearers increased by −1.28 ± 0.06 D and by −1.48 ± 0.06 D in SVL wearers. In addition to measurement of myopia by cycloplegic autorefraction, COMET provided careful measurement of other factors, including accommodation and phorias, collected by certified examiners. These data allow for a comprehensive evaluation of risk factors associated with increased progression of myopia in this group of children. Risk factors independently related to the progression of myopia included age, gender, and ethnicity, which are presented in another paper (Hyman L. IOVS 2004;45:ARVO E-Abstract 2734).
This article presents baseline accommodation and related risk factors (phoria, reading distance, and reported amount of near work), for the progression of myopia over 3 years in COMET children. Baseline myopia is also evaluated, since, like accommodation, it has been found to interact with treatment. These interactions were anticipated based on previous research in children and animals, summarized later, which provided part of the rationale for COMET. As modeled quantitatively by Flitcroft,
7 the interaction of accommodative lag, near phoria, target distance, and time spent in near viewing could be important factors that determine whether eyes become myopic and whether the myopia progresses. In addition, this model suggests that myopic children with these factors could be helped with lenses such as bifocals or PALs. Another model that incorporates these factors is that of Hung and Ciuffreda.
8 9
Distance cycloplegic autorefraction was used to assess progression of myopia, the primary outcome measure. As with all data collection procedures, autorefraction was taken on both eyes by experienced optometrists who were trained and certified on study protocols.
1 2 3 They also were masked to each child’s lens assignment.
An autorefractor/autokeratometer (ARK 700A; Nidek, Gamagori, Japan) was used to take five consecutive, reliable readings both before and after cycloplegia. The cycloplegic agent was 2 drops of 1% tropicamide, administered 4 to 6 minutes apart, after corneal anesthesia was obtained with proparacaine for all but one child for whom benoxinate was used. The COMET protocol specified that cycloplegic autorefraction occur 30 minutes after administration of the second drop of tropicamide. Tropicamide (1%) was found to be an effective cycloplegic agent in these myopic children, documented by residual accommodation measurements taken at baseline with an autorefractor (R-1; Canon, Lake Success, NY).
34
Subjective refraction was completed before cycloplegia according to a standard protocol.
1 2 3 At baseline all children received new glasses based on the distance refraction. At follow-up visits they received new glasses if the myopia correction, determined by subjective refraction, had increased by at least 0.50 D spherical equivalent from the current prescription in at least one eye. Smaller prescription changes were made if clinically indicated.
Accommodation at near (33 cm) and far (4.0 m) for 20/100 letter targets was measured monocularly using the Canon R-1 autorefractor. Because the Canon R-1, unlike most current autorefractors, has an open field of view to allow for presentation of real targets in free space, it has been the standard laboratory instrument for taking objective measurements of accommodation. The child wore a trial frame containing the best subjective spherical equivalent lens in front of the right eye, while viewing a target in free space in a dark room. The distant (4.0 m) target was a back-illuminated isolated row of 20/100 letters on an Early Treatment of Diabetic Retinopathy Study (ETDRS) chart. The contrast of the letters averaged 98% across the four participating centers. The near (33 cm) target was also a line of 20/100 letters of similar contrast. Instructions to the child were to keep the letters clear. Five accommodation readings were taken, excluding any measurements contaminated by blinks or extraneous eye movements.
Phoria at near (33 cm) and far (4.0 m) was measured using the cover test. The target was a 20/25 letter placed at 33 cm for the near measurements and at 4.0 m for the far measurements. A prism was used to neutralize the child’s eye movements.
Three measurements of each child’s normal reading distance for standardized age-appropriate text were taken at each visit, with the child wearing the latest prescription. Measurement was from the child’s eye to the page of a book using a tape measure marked in inches. Values were converted to centimeters at the Coordinating Center. Near work diaries modified from a diary used by Jensen
32 were completed for a week, soon after the study began. Children were asked to choose two typical school days and one typical weekend day on which to report activities. They checked off various activities performed at different time periods throughout the day. The data then were converted to diopter-hours, where a diopter-hour is a weighted measure that takes into account both the viewing distance and the duration of various activities.
35
Myopia in children was corrected with either SVLs or PALs (Varilux Comfort lenses with a +2.00 D addition; Essilor International, St. Petersburg, FL); all lenses were polycarbonate. PALs were fitted with the top of the channel 4.0 mm above the pupil, allowing at least 11 mm for distance vision. The fitting protocol was designed to encourage the children to use the near addition portion of the lenses, because unlike presbyopic adults, for whom the glasses are typically prescribed, children can accommodate and thus are not dependent on the near addition for close work.
Follow-up data were analyzed using an intent-to-treat principle according to the child’s original lens assignment and the last known value of the outcome measures. For the seven children lost to follow-up and thus without data at the third annual visit, progression information from the latest follow-up visit was used.
Progression of myopia was defined as the change in spherical equivalent refractive error (SER) relative to baseline (a continuous measure). A summary measure of SER was calculated for each of the five autorefraction measurements per eye, and the mean of the five SER measures was then computed. The primary analysis for progression of myopia in COMET was child based, using the average of the two eyes to evaluate the magnitude of change in SER between follow-up and baseline (Pearson correlation coefficient between the two eyes at 3 years = 0.90, and the mean interocular difference <0.25 D with a 95% confidence interval [CI] that includes 0).
The analytic strategy for this article used two main approaches. Univariate analyses were used to estimate the magnitude and variability of the risk posed by the levels of each covariate. Statistical modeling techniques were used to: (1) determine whether the covariate-specific risk interacted with the levels of the other covariates, (2) adjust the estimated covariate-specific risk for the effects of other predictors of myopia progression, and (3) test the statistical significance of these effects.
Univariate analyses were conducted using either the two-sample t-test if normality assumptions were preserved or the Wilcoxon sum rank test. These analyses were pursued partially to guide the selection of variables to be included in subsequent multivariate (modeling) analyses. Initially, each variable was evaluated to determine the magnitude of the difference in 3-year progression among its different levels.
The multivariate analyses used multiple linear regression to adjust for the potentially most prognostic covariates: age, gender, ethnicity, baseline refractive error, accommodative lag, and phoria, chosen because of their known relationship to the progression of myopia. Criteria for model building were based on first exploring and identifying an independent model and then hierarchically building an interaction model by sequential testing of each interaction term to be added to the model. These criteria were guided by the log likelihood principle.
36 Testing for interaction was conducted using specific macros in the statistical analysis software (SAS Institute Inc., SAS, Cary, NC) to obtain estimates of a possible differential effect of PALs among categories of the selected covariates, and to test for the statistical significance of differences in progression of myopia between levels of one covariate cross-classified by levels of the other potentially interacting covariates. For example, to evaluate the interaction effect of treatment by accommodative lag, the difference between treatment groups for each level of accommodative lag was evaluated and then tested to see whether these differences were the same.
Criteria for selecting multifactor interaction terms were based on the univariate findings and interpretability of the interaction terms. At most three-factor interaction terms were tested (e.g., treatment by accommodative lag by age, gender, ethnicity, baseline myopia, phoria, reading distance, or hours of near work). All reported analyses were additionally controlled for multiple comparisons (when applicable), and the resultant simultaneous 95% CIs were computed, using the approach described by Little et al.
37
The 469 children enrolled in COMET had a mean age of 9.3 years at baseline, and 52% were girls. They were ethnically diverse, with 46% white, 26% African-American, 15% Hispanic, 8% Asian, and 5% mixed. Mean baseline spherical equivalent myopia measured by cycloplegic autorefraction was −2.40 D. As reported previously, baseline characteristics were balanced, with no statistically significant differences between treatment groups. Retention was excellent, with 462 (98.5%) of 469 children completing 3-year visits. Two children changed lens assignments, both from SVLs to PALs due to binocular vision problems. Of 2939 possible study visits from the children with 3-year visits, only 10 were missed. Self-reported adherence to wearing glasses was excellent, with at least 93% of the PAL group and 96% of the SVL group reporting wearing their glasses most or all the time.
Additional interaction analyses were conducted to examine 3-year myopia progression stratified by lag of accommodation and treatment group.
Figure 1 shows the unadjusted treatment effect in children with larger and smaller accommodative lags for phoria
(Fig. 1A) , reading distance
(Fig. 1B) , baseline myopia
(Fig. 1C) , and near work duration
(Fig. 1D) . In
Figure 1A , the largest treatment effect (0.77 D) was observed in children with larger accommodative lags and near esophoria. This difference is large, because children with larger lags and near esophoria wearing PALs had the least progression (0.98 D), whereas the greatest progression (1.75 D) occurred in children with larger lags and near esophoria wearing SVLs. Children with orthophoria, regardless of the level of lag, showed an intermediate treatment effect, whereas exophoric children showed small differences between the PAL and SVL groups in the opposite direction. For reading distance, a greater treatment effect was observed in children with larger lags, especially with closer reading distances
(Fig 1B) . As shown in
Fig 1C , children with less baseline myopia and larger lags of accommodation had a larger treatment effect than did children with less myopia/smaller lags or those with more myopia. Considering near work, children who performed more hours of near work per week (>104.5 diopter-hours) and had larger lags of accommodation showed a greater treatment effect than children with more near work/smaller lags and than those with less near work
(Fig 1D) .
Table 3 shows adjusted 3-year myopia progression by level of accommodative lag for both the PAL and SVL groups for the covariates described earlier. The adjusted results are similar to the unadjusted shown in
Figure 1 . For all factors evaluated except exophoria, the greatest progression occurred in children with larger lags of accommodation who were wearing SVLs. In addition, statistically significant treatment effects were found within the baseline factors in children with larger accommodative lags, whereas no significant treatment effects were found in children with smaller lags.
With respect to phorias, the least progression (1.08 D) occurred in children with large accommodative lags and near esophoria wearing PALs and the greatest progression (1.72 D) in children with the same characteristics wearing SVLs, resulting in a statistically significant adjusted treatment effect of 0.64 D. Treatment effects were smaller in orthophores and similar for both large and small lags, whereas for exophores they were negligible. The correlation between accommodative lag and near phoria was −0.16 (P < 0.001).
For reading distance, the greatest progression occurred in children with larger accommodative lags and closer reading distances wearing SVLs (1.68 D), which, when compared with the progression found in children with the same characteristics wearing PALs (1.24 D) resulted in a statistically significant treatment effect of 0.44 D. The correlation between accommodative lag and reading distance was −0.08 (P = 0.09).
Considering baseline level of myopia, the greatest 3-year progression of myopia occurred in children with a larger accommodative lag wearing SVLs, regardless of the level of myopia. The smallest progression occurred in PAL children with a larger lag and low baseline myopia (1.11 D), which when compared with the progression in SVL children with the same characteristics (1.59 D) resulted in a statistically significant treatment effect of 0.48 D.
For near work,
Table 3 shows that children wearing SVLs with a larger accommodative lag had the most progression. Children in PALs with a larger lag who performed more near work than the median of 104.5 diopter-hours per week had myopia progression of 1.14 D, resulting in a treatment effect of 0.42 D, which was not statistically significant, perhaps due to the smaller number of subjects with near work information.
As with accommodative lag, additional interaction analyses were conducted to examine myopia progression by amount of baseline myopia and treatment group. However, unlike with the accommodation analyses, there was only one significant result, and that was for lag of accommodation. As reported previously, children with larger lags and less baseline myopia had a statistically significant 3-year treatment effect of 0.48 D.
The current results provide additional support for a role of defocus in the progression of myopia in humans, consistent with the rationale for COMET. COMET children most at risk for increased progression of myopia over 3 years had, at baseline, a larger accommodative lag in combination with near esophoria and wore the conventional treatment for myopia (SVLs). PALs slowed progression in these children and also in those with larger accommodative lags in combination with a shorter reading distance, more hours of near work, or lower baseline myopia. Retinal defocus resulting from inaccurate accommodation in some myopic children when they are engaged in close work may be a stimulus for increased axial elongation and progression of myopia, as found in animal models.
18 19 The benefits of PALs for these children are consistent with the view that retinal defocus is a stimulus to progression of myopia, and the treatment effect may be due to the ability of PALs to provide clear retinal images in these children.
Most myopic children are prescribed SVLs.
38 39 For the COMET children wearing SVLs, the level of baseline myopia was not a significant risk factor, but a large accommodative lag, assessed objectively, was. Children with larger accommodative lags wearing SVLs showed the most progression, and children with larger lags wearing PALs showed reduced progression. The same pattern held across age, gender, and ethnicity, which is presented in more detail in a separate paper (Hyman L.
IOVS 2004;45:ARVO E-Abstract 2734). Briefly, younger children and girls with larger accommodative lags wearing SVLs showed the most progression. The number of subjects was large only for African-American and white children; both ethnic groups showed this same pattern of progression based on accommodative lag and lens type.
When phoria was combined with accommodation, progression at both 1 and 3 years was found to be smallest in children wearing PALs who had both a large accommodative lag and near esophoria and largest in children wearing SVLs with the same baseline characteristics. In part, because near esophoria has been strongly identified as a risk factor for progression of myopia, Fulk et al.
40 conducted a clinical trial of 84 myopic children with near esophoria, randomized to either bifocals or SVLs. Overall, a 0.25-D treatment effect was found, similar in magnitude to other studies that did not limit enrollment by phoria status.
4 5 6 Because accommodation was not measured in these other studies, it is not possible to evaluate the progression of myopia and the treatment effect by lag of accommodation. The COMET results, however, suggest that the diagnosis of near esophoria in the absence of information on accommodation may not be sufficient to determine the best spectacle lens treatment for myopic children.
Measurement of accommodation and phoria were combined in a retrospective reanalysis of patient records from three practices,
41 using near, binocular, crossed-cylinder findings as a measure of lag of accommodation. Even though the number of subjects was very small, a pattern similar to the present results was found. Greater progression occurred in myopic children with large (≥0.50 D) lags and near esophoria wearing SVLs (0.55 D/y) compared with those with the same characteristics wearing bifocals (0.26 D/y). The sample was too small to evaluate results for children with lags less than 0.50 D. Looking at lags alone, regardless of phoria status, progression for children with large lags was found to be significantly greater in the SVL group (0.48 D/y) than in the bifocal group (0.25 D/y). In patients with small lags, there was no difference in annual progression of myopia by lens type, approximately 0.40 D/y in each treatment group, a finding similar to that in the present study. These data suggest that careful measurement of accommodative lags is important for determining the best spectacle lens treatment for myopic children and presumably will be important for whatever type of treatment (e.g., contact lenses, drugs) is being considered.
To account for the observed association between larger accommodative lags and near esophoria in previous studies, it has been suggested that an esophoric child must relax accommodation to reduce accommodative convergence and thus maintain single binocular vision.
30 31 In the present study the correlation between these two factors was found to be low, though significant, and so this explanation cannot be the whole story.
Baseline reading distance emerged as a risk factor for progression among children with close reading distances and larger accommodative lags wearing SVLs. Rosenfield et al.
42 reported that children of ages (6.4–10.75 years) similar to those in the COMET group had a mean reading distance of 27.2 cm, with no increase in reading distance over that age range. The median reading distance in the COMET group was 31.2 cm, slightly greater than that in the earlier report. Because our near targets for measuring accommodation were at 33 cm, this distance was most appropriate for the COMET children. Myopic children are reported to hold text and video games closer than emmetropic children.
27 The COMET data showed that a near reading distance, especially in children with large lags wearing SVLs, led to faster progression, and that PALs slowed progression in this group of children.
The near work data present a plausible pattern of results, even with a reduced sample size and the inherent problems in assessing near work by questionnaire. A significant treatment effect at 1 year (which approached significance at 3 years) was found only for children with more hours of near work in combination with larger accommodative lags, suggesting that the lens intervention was more effective for those children who most likely experienced more blurred near vision. More sophisticated ways of assessing near work are being explored.
43 In addition, temporal factors increasingly are found to play a role in animal models of myopia,
44 45 suggesting that the timing of periods of near and distance viewing, and the type of spectacles worn or not worn, are likely to be of importance. Even with these limitations, the present data suggest that PALs may be beneficial for children with larger accommodative lags who perform extensive near work activities.
The literature provides limited data on the risk of myopia progression for different amounts of presenting myopia. COMET children wearing the conventional treatment, SVLs, had similar progression over 3 years, whether they had lower or higher baseline myopia. The children in PALs with lower baseline myopia had reduced progression compared with those in PALs who had higher myopia. Therefore, a statistically significant treatment effect was found only in children with lower baseline myopia. This result suggests that once the myopization process has started and passed some critical level, it may be more difficult to intervene with an optical treatment.
The present results suggest that the main 3-year treatment effect in COMET of 0.20 D, which was found at 1 year and sustained over the next 2 years of follow-up,
1 is more representative of certain subsets of COMET children than others. Children with smaller baseline accommodative lags showed a limited treatment effect which was similar over 3 years, whereas those with larger lags at study onset, in combination with near esophoria, a closer reading distance, lower myopia, or more hours of near work, showed larger treatment effects that grew over 3 years. Increases in the size of the treatment effect between 1 and 3 years (approximately 0.20 D) were smaller than the effect that developed between baseline and 1 year. This result suggests that for children with larger lags at baseline, accommodation may have improved over the course of the study, leading to slowed efficacy of PALs. Future analyses of COMET data will show whether changes in the lag of accommodation over 3 years accounted for the present results.
Additional analyses also will show whether there are changes in the accommodative convergence-to-accommodation (AC/A) ratio over time and whether they are associated with progression of myopia. Elevated AC/A ratios have been linked to the development and progression of myopia.
31 46 Higher AC/A ratios are found in myopic than in emmetropic children, because myopes have significantly reduced accommodation and slightly increased accommodative convergence.
31 Accommodation and phoria measurements from COMET children at baseline and each year of follow-up will be used to calculate AC/A ratios, to be presented in a future paper.
In the United States, children who demonstrate near esophoria and poor accommodation, regardless of refractive error, often are prescribed PALs or bifocals to improve their visual performance. These same children, if myopic, may have an additional benefit of slowed progression of myopia. However, the present analyses, while hypothesis-driven, are based on subsets of the full COMET data set representing 469 children. Therefore, any clinical recommendations will have to await results from a follow-up study to establish the efficacy of PALs in slowing the progression of myopia in children with the risk profile reported in this article.
New England College of Optometry, Boston, Massachusetts: Daniel Kurtz (Principal Investigator); Erik Weissberg (Optometrist 6/99–present); Bruce Moore (Optometrist, until 6/99); Robert Owens (Primary Optician); Justin Smith (Clinic Coordinator 1/01–present); Sheila Martin (Clinic Coordinator, until 9/98); Joanne Bolden (Coordinator 10/98–present); Benny Jaramillo (Back-up Optician 3/00–present); Stacy Hamlett (Back-up Optician 6/98–5/00); Patricia Kowalski (Consulting Optometrist, until 6/01); Jennifer Hazelwood (Consulting Optometrist 7/01–present).
Pennsylvania College of Optometry, Philadelphia, Pennsylvania: Mitchell Scheiman (Principal Investigator); Kathleen Zinzer (Optometrist); Timothy Lancaster (Optician, until 6/99); Theresa Elliott (Optician, until 8/01); Mark Bernhardt (Optician 6/99–5/00); Dan Ferrara (Optician 7/00–7/01); Jeff Miles (Optician 8/01–present); Abby Grossman (Clinic Coordinator 8/01–present); Mariel Torres (Clinic Coordinator, until 6/00); Heather Jones (Clinic Coordinator 8/00–7/01); Melissa Madigan-Carr (Coordinator 7/01–present); Theresa Sanogo (Back-up Coordinator 7/99–present); JoAnn Bailey (Consulting Optometrist).
University of Alabama at Birmingham School of Optometry, Birmingham, Alabama: Wendy Marsh-Tootle (Principal Investigator); Katherine Niemann (Optometrist 9/98–present); Kristine Becker (Ophthalmic Consultant 7/99–present); James Raley (Optician, until 4/99); Angela Rawden (Back-up Optician, until 9/98); Catherine Baldwin (Primary Optician & Clinic Coordinator 10/98–present); Nicholas Harris (Clinic Coordinator 3/98–9/99); Trana Mars (Back-up Clinic Coordinator 10/97–present); Robert Rutstein (Consulting Optometrist).
University of Houston College of Optometry, Houston, Texas: Ruth Manny (Principal Investigator); Connie Crossnoe (Optometrist); Sheila Deatherage (Optician); Charles Dudonis (Optician); Sally Henry (Clinic Coordinator, until 8/98); Jennifer McLeod (Clinic Coordinator 9/98–present); Julio Quiralte (Backup Coordinator 1/98–present); Karen Fern (Consulting Optometrist).
STUDY CHAIR’S OFFICE: New England College of Optometry, Boston, Massachusetts: Jane Gwiazda (Study Chair/Principal Investigator); Kenneth Grice (Study Coordinator, until 7/99); Christine Fortunato (Study Coordinator 8/99–9/00); Cara Weber (Study Coordinator 10/00–present); Rosanna Pacella (Research Assistant, until 10/98); Thomas Norton (Consultant, University of Alabama at Birmingham).
COORDINATING CENTER: Department of Preventive Medicine, Stony Brook University Health Sciences Center, Stony Brook, New York: Leslie Hyman (Principal Investigator); M. Cristina Leske (Co-Principal Investigator); Mohamed Hussein (Co-Investigator/Biostatistician); Elinor Schoenfeld (Epidemiologist); Lynette Dias (Study Coordinator 6/98–present); Rachel Harrison (Study Coordinator 4/97–3/98); Jennifer Thomas (Assistant Study Coordinator 12/00–present); Cristi Rau (Assistant Study Coordinator 2/99–11/00); Elissa Schnall (Assistant Study Coordinator 11/97–11/98); Wen Zhu (Senior Programmer); Ying Wang (Data Analyst 1/00–present); Ahmed Yassin (Data Analyst 1/98–1/99); Lauretta Passanant (Project Assistant 2/98–present); Maria Rodriguez (Project Assistant 10/00–present); Allison Schmertz (Project Assistant 1/98–12/98); Ann Park (Project Assistant 1/99–4/00); Phyllis Neuschwender (Administrative Assistant, until 11/99); Geeta Veeraraghavan (Administrative Assistant 12/99–4/01); Angela Santomarco (Administrative Assistant 7/01–present).
National Eye Institute, Bethesda, Maryland: Donald Everett (Program Director, Collaborative Clinical Trials Branch).